Sickle cell awareness month, observed annually in September, is a time to raise awareness about sickle cell disease, a genetic blood disorder that affects millions of people worldwide. The Pfizer drug, Oxbryta, a sickle cell drug approved in 2019, is now ...

Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming that it was aware of the potential risks. Depo-Provera ...